Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Amgen, Foundation, Intelligent, Johnson, Merakris, Nxera, Pasithea, Roche, Santhera.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, Cercare, Foundation, Haisco, Kamada, Mannkind, Nouscom, Outlook, Polypid, Shionogi, Surgentec, Vertex, Wockhardt.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Boehringer Ingelheim, Cornerstone Robotics, Daiichi Sankyo, Dizal, Gene Solutions, H. Lundbeck, Innocare, Optimi Health, Skia, Vanda, Zydus.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Coredio, Johnson, Merck, Neuropace, Optimi, Replimune, Skia, Spectral, Tempus, Zydus.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Autobahn, Cornerstone, Dyne, Gilead, H. Lundbeck, Microbot, Outlook, Pfizer, Pharming, Spectral, Toby.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Agios, Astellas, Astrazeneca, Boehringer, Daiichi, Gilead, Merck, Novo, Regeneron, Teva.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo, GSK, H. Lundbeck, Hutchmed, Innovent, Junshi, Lupin, Maat, Mabwell.